Charles Schwab’s Akoya BioSciences AKYA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-63,026
| Closed | -$87.6K | – | 3498 |
|
|
2025
Q1 | $87.6K | Buy |
63,026
+24
| +0% | +$33 | ﹤0.01% | 3364 |
|
|
2024
Q4 | $144K | Hold |
63,002
| – | – | ﹤0.01% | 3365 |
|
|
2024
Q3 | $171K | Sell |
63,002
-112,886
| -64% | -$307K | ﹤0.01% | 3350 |
|
|
2024
Q2 | $412K | Buy |
175,888
+4,112
| +2% | +$9.62K | ﹤0.01% | 3272 |
|
|
2024
Q1 | $806K | Sell |
171,776
-33,073
| -16% | -$155K | ﹤0.01% | 2858 |
|
|
2023
Q4 | $1,000K | Buy |
204,849
+51,410
| +34% | +$251K | ﹤0.01% | 2831 |
|
|
2023
Q3 | $713K | Buy |
153,439
+23,132
| +18% | +$108K | ﹤0.01% | 2912 |
|
|
2023
Q2 | $963K | Buy |
130,307
+6,294
| +5% | +$46.5K | ﹤0.01% | 2784 |
|
|
2023
Q1 | $1.01M | Sell |
124,013
-1,203
| -1% | -$9.84K | ﹤0.01% | 2724 |
|
|
2022
Q4 | $1.2M | Buy |
125,216
+2,350
| +2% | +$22.5K | ﹤0.01% | 2721 |
|
|
2022
Q3 | $1.44M | Buy |
122,866
+53,335
| +77% | +$627K | ﹤0.01% | 2683 |
|
|
2022
Q2 | $894K | Buy |
69,531
+2,130
| +3% | +$27.4K | ﹤0.01% | 2835 |
|
|
2022
Q1 | $741K | Buy |
67,401
+7,243
| +12% | +$79.6K | ﹤0.01% | 2969 |
|
|
2021
Q4 | $922K | Buy |
60,158
+13,392
| +29% | +$205K | ﹤0.01% | 2945 |
|
|
2021
Q3 | $653K | Sell |
46,766
-3,756
| -7% | -$52.4K | ﹤0.01% | 3050 |
|
|
2021
Q2 | $978K | Buy |
+50,522
| New | +$978K | ﹤0.01% | 2941 |
|